Cepheid announces test categorized as 'moderate complexity' by FDA Cepheid announced the FDA has categorized Cepheid's Xpert CT/NG test as 'Moderate Complexity' under the Clinical Laboratory Improvement Amendments. Xpert CT/NG is a qualitative in vitro molecular diagnostic test for the detection and differentiation of Chlamydia trachomatis and Neisseria gonorrhoeae.
News For CPHD From The Last 14 Days
Check below for free stories on CPHD the last two weeks.
